Park Avenue Securities LLC Buys 3,867 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Park Avenue Securities LLC lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 24.6% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 19,591 shares of the medical equipment provider's stock after purchasing an additional 3,867 shares during the period. Park Avenue Securities LLC's holdings in Intuitive Surgical were worth $9,703,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. Atala Financial Inc bought a new stake in Intuitive Surgical during the 4th quarter valued at about $25,000. Parvin Asset Management LLC purchased a new stake in Intuitive Surgical during the fourth quarter worth $26,000. Global Financial Private Client LLC raised its position in Intuitive Surgical by 253.3% during the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after acquiring an additional 38 shares during the period. BankPlus Trust Department acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $28,000. Finally, Hurley Capital LLC acquired a new stake in Intuitive Surgical during the fourth quarter worth about $28,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have recently commented on ISRG. Robert W. Baird lowered their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Truist Financial decreased their target price on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research report on Wednesday, April 23rd. BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the stock a "buy" rating in a research report on Monday, April 14th. Piper Sandler reduced their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a report on Wednesday, April 23rd. Finally, Citigroup reissued a "buy" rating and set a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Four analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $596.05.

Intuitive Surgical Price Performance

Shares of ISRG opened at $557.08 on Friday. The business's fifty day moving average price is $521.99 and its 200 day moving average price is $539.24. Intuitive Surgical, Inc. has a 12-month low of $413.52 and a 12-month high of $616.00. The stock has a market capitalization of $199.67 billion, a PE ratio of 86.91, a price-to-earnings-growth ratio of 5.85 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period last year, the company earned $1.50 earnings per share. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Jami K. Nachtsheim sold 2,400 shares of the business's stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the sale, the director now directly owns 6,371 shares in the company, valued at approximately $3,312,920. The trade was a 27.36% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the transaction, the senior vice president now directly owns 907 shares in the company, valued at approximately $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 25,443 shares of company stock valued at $12,692,195 over the last three months. Company insiders own 0.70% of the company's stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.